Pollinex Quattro Tree: allergy vaccine
| Autor: | Consuelo L. Saccar, Sandra M. Gawchik |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Pharmacology
Clinical Trials as Topic Vaccines Allergy Pediatrics medicine.medical_specialty business.industry PQ tree medicine.medical_treatment Clinical Biochemistry Allergy vaccine Specific immunotherapy medicine.disease Trees Tree (data structure) Drug Discovery Immunology Hypersensitivity medicine Humans Seasonal Rhinitis business Pollinex Quattro Adjuvant |
| Zdroj: | Expert Opinion on Biological Therapy. 9:377-382 |
| ISSN: | 1744-7682 1471-2598 |
| DOI: | 10.1517/14712590802699596 |
| Popis: | An overview of short-term specific immunotherapy (ST-SIT) highlighting Pollinex Quattro (PQ) Tree is presented. The product development of this novel allergy vaccine using modifying agent glutaraldehyde, adjuvant monophosphoryl lipid and L-tyrosine have heralded a superior ST-SIT. Since 1999 when PQ was founded in Germany, various research trials assessing both the standardization and clinical studies have been done. A review of these studies demonstrates the efficacy and safety of PQ Tree in both pediatric and adult trials. The uniqueness of this product allows a shorter course of four pre-seasonal injections to provide control of allergy symptomatology in seasonal rhinitis patients. The PQ Tree product studies show a similar efficacy and safety profile to the grass formulation trial. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|